Drugs With Roots in Ayurvedic Sources: Reserpine and Others
How reserpine, from the Rauwolfia plant used in Indian medicine, became a tested drug, and what Mucuna and guggul show about the gap between a plant used traditionally and a proven treatment.
Content last updated . This page has not been medically reviewed.
A drug is not the same as a herb
Some modern medicines began with plants that traditional medical systems used. This page looks at what happened when researchers isolated, tested and dosed a compound from one such plant. It is about drug development, not an endorsement of the herbs. A purified drug has a known identity and strength and has been tested in trials. A raw herb or an unregulated product may vary widely in what it contains.If you think someone has taken a harmful amount of a product, call 911 in the US or US Poison Help at 1-800-222-1222; other countries are listed at Poison Help by Country.
Reserpine and Rauwolfia serpentina
What the history says. Rauwolfia serpentina is a tropical woody plant of Asia, South America and Africa. A historical review says extracts of rauwolfia and similar plants were used in Hindu medicine for snakebite, insomnia, insanity and many other complaints. [1] The first modern paper on the whole root's therapeutic use appeared in the Indian Medical Journal in 1931, and in 1949 Vakil reported rauwolfia's blood-pressure effect in the British Heart Journal. [1] Swiss chemists at Ciba then analyzed the plant's alkaloids, and in 1952 reserpine was introduced for hypertension. [1] The review calls reserpine the first potent drug widely used for long-term treatment of high blood pressure. [1]What trials show. A Cochrane review of four randomized trials (237 people) found reserpine lowered systolic blood pressure compared with placebo (about 8 mmHg on average), roughly as much as other first-line drugs, but too few trials to define the dose-response or establish its role today. [2] Evidence: established as a drug effect, with limited modern trial data. The review's finding applies to reserpine as a medicine, not to Rauwolfia root products.
Mood. Reserpine is rarely used today, largely because of an assumption that it causes depression. A 2023 systematic review found the link inconsistent: some studies showed depression-like effects, some none, and some possible antidepressant effects, and 30 of 35 studies had a high risk of bias. [3]
Safety when it turns up in a product. In one reported case, a man developed Parkinsonism and depression from a herbal medicine containing reserpine, and doctors recognized it late. [4] Another report describes a man with high blood pressure taking an Ayurvedic medicine that contained reserpine, a drug the authors said had been withdrawn from conventional medicine because of its side effects. [5] Ask a clinician or pharmacist about any herbal product you take, and tell them if you have had unexplained symptoms after starting one.
Mucuna pruriens and levodopa
Mucuna pruriens (kapikacchu) seed powder has been used in traditional Indian medicine for parkinsonism. [6] The seeds contain L-dopa, the main component of standard Parkinson medicine. One study measured 0.58% to 6.42% L-dopa across 56 seed accessions and in lab extraction tests an average of about half of the L-dopa degraded. [7]Evidence: a small randomized crossover study of 8 people with Parkinson disease found a faster onset and longer "on" time than standard levodopa/carbidopa, without more dyskinesia. [6] A 2025 review of 5 trials (108 participants) found improved motor symptoms, but three trials were low quality and the authors said more high-quality trials are needed. [8] Promising but limited. Because L-dopa content varies, people with Parkinson disease should not swap prescribed medicine for a seed product. See Kapikacchu (Mucuna Pruriens) in Ayurveda.
Guggul: a plausible lead that did not hold up
Guggul (Commiphora mukul) extracts have been used in Asia for cholesterol, and researchers had proposed a mechanism. [9] A US randomized trial of 103 adults found guggulipid did not lower cholesterol, LDL rose 4% to 5%, and six participants had a hypersensitivity rash. [9] A later meta-analysis of other trials reported reductions. [10] Mixed. See Guggul.Other examples
We searched for further well-documented drug-development examples from Ayurvedic plants and found no sources we could read that support a firm claim. Proper evidence not found for others, so none are listed here.What this means for readers
A plant used for centuries can contain a real drug, which is exactly why unlabeled or adulterated products can be risky. Equally, a traditional use does not guarantee benefit. For product safety see Adulteration and Undeclared Drugs in Ayurvedic Products and Ayurvedic Herbs and Prescription Medicines. For the wider evidence picture see Does Ayurveda Work?.Frequently asked questions
Is reserpine an Ayurvedic drug?
Reserpine is a purified compound from Rauwolfia serpentina, a plant used in Indian traditional medicine. As a drug it was developed and tested by modern methods. [1]
Does reserpine lower blood pressure?
Yes. A Cochrane review found a systolic reduction compared with placebo, with few trials. [2]
Does reserpine cause depression?
Evidence is inconsistent and mostly at high risk of bias. [3]
Is Mucuna pruriens as good as levodopa?
Small studies suggest promise, but evidence is limited and seed L-dopa content varies. Do not replace prescribed medicine. [8][7]
Can Ayurvedic products contain hidden drugs?
Yes. A case report described a man taking an Ayurvedic product that contained reserpine. [5]
References
- Jerie. Milestones of cardiovascular therapy. IV. Reserpine. Cas Lek Cesk 2007. Abstract read 2026-10-22.
- Shamon and Perez. Blood pressure-lowering efficacy of reserpine for primary hypertension. Cochrane Database Syst Rev 2016. Abstract read 2026-10-22.
- Strawbridge et al. The effects of reserpine on depression: a systematic review. J Psychopharmacol 2023. Abstract read 2026-10-22.
- Rijntjes and Meyer. No free lunch with herbal preparations: lessons from a case of parkinsonism and depression due to herbal medicine containing reserpine. Front Neurol 2019. Abstract read 2026-10-22.
- Paudyal et al. Adverse events with ayurvedic medicines: possible adulteration and some inherent toxicities. Wellcome Open Res 2019. Abstract read 2026-10-22.
- Katzenschlager et al. Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study. J Neurol Neurosurg Psychiatry 2004. Abstract read 2026-10-22.
- Pulikkalpura et al. Levodopa in Mucuna pruriens and its degradation. Sci Rep 2015. Abstract read 2026-10-22.
- Hammoud et al. Mucuna pruriens treatment for Parkinson disease: a systematic review of clinical trials. Parkinsons Dis 2025. Abstract read 2026-10-22.
- Szapary et al. Guggulipid for the treatment of hypercholesterolemia: a randomized controlled trial. JAMA 2003. Abstract read 2026-10-22.
- Gyawali et al. A systematic review and meta-analysis of Ayurvedic herbal preparations for hypercholesterolemia. Medicina 2021. Abstract read 2026-10-22.